Lobbying

Amneal Pharmaceutical's latest lobbying report covers Q4 2023, at $80K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Amneal Pharmaceutical

Latest quarter
No record
Q2 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Amneal Pharmaceutical lobbying by quarter
Amneal Pharmaceutical lobbying by quarter
QuarterAmountReports
Q4 2022$40K1
Q1 2023$50K1
Q2 2023$80K1
Q3 2023$80K1
Q4 2023$80K1
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00

Policy issues the reports name

  • Health issues5 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE5 reports
  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Michael Best Strategies$330K5 quarters

Former officials lobbying for it

Former position
ALEXANDER ANGELSONSpecial Assistant to the President, White House Legislative AffairsQ3 2023
ERIK MICHAEL BERDYSpecial Assistant to the Chairman of the Joint Chiefs of Staff for Legislative Affairs; Legislative Assistant to the Chief of Staff of the Army; Deputy Military Legislative Assistant, SenateQ3 2023
LEWIS POLAYIntern, House of RepresentativesQ3 2023
SARAH HELTONIntern, House of RepresentativesQ3 2023
ANDREA RICCIODeputy Director Democratic Policy and Communications Committee, House of RepresentativesQ2 2023
BRIDGET VISCONTIConfidential Assistant to the USTR and Chief of Staff, Office of the United States Representative, Executive Office of the President; Executive Office Coordinator- Council of Economic Advisers, Executive Office of the PresidentQ1 2023

Lobbying reports

Filed by
24/04/22for Q4 2023Michael Best Strategies$80K
24/01/19for Q4 2023Michael Best Strategies$80K
23/10/20for Q3 2023Michael Best Strategies$80K
23/07/19for Q2 2023Michael Best Strategies$80K
23/04/19for Q1 2023Michael Best Strategies$50K
23/01/20for Q4 2022Michael Best Strategies$40K